Summary Response Assessment in Neuro-Oncology (RANO) response criteria have been
established and were updated in 2023 for MRI-based response evaluation of diffuse …

Fluorescence imaging is one of the most promising approaches to achieve intraoperative
assessment of the tumor/normal tissue margins during cancer surgery. This is critical to …

Antibody-drug conjugates (ADCs) for the treatment of cancer aim to achieve selective
delivery of a cytotoxic payload to tumor cells while sparing normal tissue. In vivo, multiple …

Activatable dual‐modal molecular imaging probes present a promising tool for the diagnosis
of malignant tumors. However, synchronously enhancing dual‐modal imaging signals under …

Pazopanib (PAZ), an oral multi-tyrosine kinase inhibitor, demonstrates promising cytostatic
activities against various human cancers. However, its clinical utility is limited by substantial …

Enzymatic molecular in situ self-assembly (E-MISA) that enables the synthesis of high-order
nanostructures from synthetic small molecules inside a living subject has emerged as a …

Metabolic reprogramming drives the development of an immunosuppressive tumor
microenvironment (TME) through various pathways, contributing to cancer progression and …

Magnetic particle imaging (MPI) has demonstrated versatile applications in biomedicine,
including tumor imaging, cell tracking, and image‐guided hyperthermia. Despite these …

The liver is essential for metabolic homeostasis. The onset of liver cancer is often
accompanied by dysregulated liver function, leading to metabolic rearrangements …

Multimodal biomedical imaging and imaging‐guided therapy have garnered extensive
attention owing to the aid of nanoagents with the aim of further improving the therapeutic …